My next question is for the Minister of Health. Mr. Chair, on Wednesday, February 26, after the death of 23-year-old Chantelle Lindsay from Nova Scotia due to complications from cystic fibrosis, I asked the Prime Minister whether the government was going to make Trikafta, which might have saved Chantelle's life, available to Canadians. Now that almost 12 weeks have passed, we understand that Vertex Pharmaceuticals has not yet applied to Health Canada for study. Many of my Conservative colleagues and I have recently sent a letter to the minister asking for an update on how we support those negotiations with Vertex. Can the Minister of Health tell us when this drug will be available to CF patients in Canada?
Honourable minister, the floor is yours.
Thank you very much, Mr. Chair. My heart goes out to the family of Chantelle, who are obviously suffering an unbearable loss. I agree with the member that we want to make sure that effective drugs are available in Canada. As the member has pointed out, Vertex has not applied to sell Trikafta in Canada. However, there is the special access program that makes drugs like Trikafta available. In fact, the majority of people who have applied through the special access program to get access to the drug have received access. I would encourage the member to continue his correspondence with the manufacturer, as will we.
Mr. d'Entremont, you have 36 seconds.